Abstract
Background: During Covid-19 pandemic, the Italian National Healthcare Service has faced increasing pressure, especially in Northern Italy. Even in less-affected regions, such as Tuscany, the changes in the healthcare system to prevent Covid-19 spread resulted in difficulty in treating time-dependent disorders like ischemic stroke rapidly.
Objective: The aim of our study was to assess the outcome after acute ischemic stroke treatments during the Covid-19 spread in comparison with a similar period of the previous year in Siena-Hospital (Hub center in the South-East Tuscany).
Methods: We enrolled all patients admitted to Siena-Hospital for ischemic stroke and submitted them to acute treatments (intravenous and/or mechanical thrombolysis) between February 21st and May 18th, 2020 (study group, n:38) and compared the results with ischemic strokes acutely treated in a similar period in 2019 (control group, n:39). The modified Rankin scale score was assessed at 90 days to evaluate a 3-month clinical outcome.
Results: In the study group, the time from symptoms onset to hospital arrival and the door-to-groin puncture time were significantly more prolonged than in the control group. In moderate-severe strokes, the 3-month mortality was significantly higher in the study group (31% vs. 6%; p=0.01), and the number of patients with poor functional outcomes was significantly higher in the study group (73% vs. 44%; p=0.03).
Conclusion: During the lockdown period due to Covid-19 pandemic, patients with acute ischemic stroke had a worse prognosis. These findings suggest the need to improve the health system organization to guarantee an appropriate treatment during the pandemic, including the patients that are not affected by Covid-19.
Keywords: Ischemic stroke, thrombolysis, alteplase, mechanical thrombolysis, COVID-19, treatment outcome.
Graphical Abstract
[http://dx.doi.org/10.1016/S2468-2667(20)30074-8] [PMID: 32220653]
[http://dx.doi.org/10.1007/s00415-020-10200-2] [PMID: 32954445]
[http://dx.doi.org/10.1161/01.STR.24.1.35] [PMID: 7678184]
[http://dx.doi.org/10.1161/STR.0000000000000158] [PMID: 29367334]
[http://dx.doi.org/10.1159/000442715] [PMID: 27051410]
[http://dx.doi.org/10.1136/neurintsurg-2020-016299] [PMID: 32467244]
[http://dx.doi.org/10.1017/dmp.2020.338] [PMID: 32907670]
[http://dx.doi.org/10.1016/j.resuscitation.2020.06.031] [PMID: 32653572]
[http://dx.doi.org/10.1093/eurheartj/ehaa508] [PMID: 32562486]
[http://dx.doi.org/10.1161/STROKEAHA.120.033160] [PMID: 33356382]
[http://dx.doi.org/10.1161/STROKEAHA.120.031293] [PMID: 33059543]
[http://dx.doi.org/10.1161/STROKEAHA.120.032789] [PMID: 33250041]
[http://dx.doi.org/10.1161/STROKEAHA.120.030100] [PMID: 32347790]